PWAM
IRWD icon

Private Wealth Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Private Wealth Asset Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.1K Buy
+6,000
New +$24.6K ﹤0.01% 552
2025
Q2 		– Sell
-209
Closed -$307 – 1174
2025
Q1 		$307 Buy
+209
New +$498 ﹤0.01% 1027

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Private Wealth Asset Management's IRWD Position: Q1 2026 in Review

Private Wealth Asset Management opened a new position in Ironwood Pharmaceuticals (IRWD) in Q1 2026: 6,000 shares worth $21.1K. The stake represents ﹤0.01% of the portfolio and ranks #552 among its holdings. This is a return to the name: Private Wealth Asset Management previously reported a position in IRWD as recently as Q1 2025.

Private Wealth Asset Management first reported a position in IRWD in Q1 2025 and has held it in 2 quarters since. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Private Wealth Asset Management held 6,000 shares of Ironwood Pharmaceuticals worth $21.1K as of Q1 2026.
  • Ironwood Pharmaceuticals was a new Private Wealth Asset Management position in Q1 2026.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Private Wealth Asset Management's portfolio in Q1 2026, its #552 holding.
  • Private Wealth Asset Management first reported a position in Ironwood Pharmaceuticals in Q1 2025 and has held it in 2 quarters since.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Private Wealth Asset Management's 13F filing for Q1 2026, filed 6 May 2026.